Information Journal Paper
APA:
Copy. (2020). Safety and efficacy of intranasal recombinant human interferon alfa 2b as prophylaxis for COVID-19 in patients on a hemodialysis program. JOURNAL OF RENAL ENDOCRINOLOGY, 7(1), 0-0. SID. https://sid.ir/paper/1006044/en
Vancouver:
Copy. Safety and efficacy of intranasal recombinant human interferon alfa 2b as prophylaxis for COVID-19 in patients on a hemodialysis program. JOURNAL OF RENAL ENDOCRINOLOGY[Internet]. 2020;7(1):0-0. Available from: https://sid.ir/paper/1006044/en
IEEE:
Copy, “Safety and efficacy of intranasal recombinant human interferon alfa 2b as prophylaxis for COVID-19 in patients on a hemodialysis program,” JOURNAL OF RENAL ENDOCRINOLOGY, vol. 7, no. 1, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/1006044/en